Boustead Singapore Limited (F9D) Fair Value & Analysis
Industrials · SG · Market cap 1.0B SGD
Fair value as of: Jul 4, 2026
From 13 valuation models · updated today
Share price −0.5% over the past month.
Price vs Fair Value (12 months)
12‑month range 1.45 SGD – 2.57 SGD · fair‑value band 3.14 SGD – 5.22 SGD · the 2.09 SGD price screens below the 4.18 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Boustead Singapore Limited (F9D) currently trades at 2.09 SGD, while our model-based Fair Value estimate is 4.18 SGD — implying the stock looks roughly 100.0% undervalued today. We read business quality at 62/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Boustead Singapore Limited generated revenue of 624M SGD at a net margin of 37.3%. Revenue grew 42.5% year over year. It earns a return on equity of 33.5%. The stock trades on a trailing P/E of 4.4. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Boustead Singapore Limited, an investment holding company, provides energy engineering, real estate, geospatial, and healthcare technology solutions in Singapore, Australia, Malaysia, the United States, Europe, rest of Asia Pacific, North and South America, the Middle East, and Africa. The company designs, engineers, and supplies direct-fired process heater systems, waste heat recovery units, and process control systems for the oil and gas, and petrochemical industries; designs, produces, commissions, and maintains wellhead control panels and hydraulic power units, integrated control and safety shutdown systems, telemetry systems, and chemical injection skids; and deals in rehabilitation equipment and related biomedical products. It also distributes professional services and solutions to Esri ArcGIS, the geographic information system, and smart mapping and location analytics platform; distributes, rents and repairs, and maintains medical appliance and sport science; and provides …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Boustead Singapore Limited reported revenue of 624M SGD in FY2026 versus 632M SGD in FY2022, a compound −0.3%/yr. Reported net income was 233M SGD in FY2026, compounding +66.1%/yr from FY2022.
Is F9D fairly valued? → Check now
Similar stocks
6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Honeywell International Inc HON | C$25.91 | C$10.44 | -60% |
| CITIC Limited 0267 | HK$12.30 | HK$37.22 | +203% |
| Swire Pacific Limited 0019 | HK$81.70 | HK$13.77 | -83% |
| CK Hutchison Holdings 0001 | HK$68.20 | HK$146.23 | +114% |
| Itaúsa S.A ITSA3 | R$13.10 | R$25.73 | +96% |
| SK Inc 034730 | 730,000 KRW | 615,077 KRW | -16% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Boustead Singapore Limited (F9D) undervalued?
What is the fair value of F9D?
What is the quality score of F9D?
What is the revenue of Boustead Singapore Limited (F9D)?
What is the net profit margin of F9D?
Does Boustead Singapore Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.